Epitopea Announces First Patient Dosed in OVACT Phase 1/1b Clinical Trial of CryptiVax™-1001 in Advanced High-Grade Serous Ovarian Cancer - The Manila Times
1fuente
1país
1idioma
04:08detectada el 09/11 (10:08 UTC)
04:08última novedad, 09/11
1noticia
Cadena de publicación
La publicó primero The Manila Times (Filipinas) el 09/11 a las 04:08 (10:08 UTC).
-
04:0809/11, 10:08 UTC
MTThe Manila Times news.google.comEpitopea Announces First Patient Dosed in OVACT Phase 1/1b Clinical Trial of CryptiVax™-1001 in Advanced High-Grade Serous Ovarian Cancer - The Manila Times
PH EN Primera
Datos de esta historia: JSON


